Over 152,000 Doses of Pfizer-BioNTech Vaccine Delivered to Tajikistan
Read also
DUSHANBE, 31.01.2022 (NIAT Khovar) – Today, 152,100 doses of the Pfizer-BioNTech vaccine were delivered to Tajikistan as part of the COVAX mechanism and the program for the fair distribution of doses of vaccines against COVID-19.
Currently, Tajik citizens are vaccinated against coronavirus with Sputnik V, AstraZeneca, CoronaVac, Moderna, and Pfizer vaccines.
As of January 20, 4,355,582 people or 75.6% of the country’s population has been vaccinated against COVID-19. To date, 3,636,802 people also received the second dose of the vaccine, which constitutes 63.1% of the population.
Lonely Planet Includes Tajikistan among the World’s Best Travel Experiences
Emomali Rahmon and Xi Jinping Highlight Significance of Launching Direct Passenger Flights between Dushanbe and Beijing
Tajikistan Provides Key Platform for Science–Policy Dialogue on Glacier Preservation, Says UCA Researcher
CGTN Journalist Praises Tajikistan’s Leadership on Glaciers’ Issues and Highlights China-Tajikistan Cooperation
UN Women Official Stresses the Role of Women in Climate Action at Glaciers’ Conference in Dushanbe
Japanese Researcher Highlights Tajikistan’s Role in Regional Water Security at High-Level Glaciers’ Conference
“This is Not Just Ice – This is Life”: UN Deputy Chief Calls for Urgent Action at Glaciers Conference in Dushanbe
Dushanbe Hosts Landmark International High-Level Conference on Glaciers’ Preservation
The Climate Crisis Is Primarily a Crisis of Children’s Rights
Chinese Scientist Highlights Glacier Retreat as a Tangible Reality for Tajikistan, the Region, and the World
Dushanbe Conference Launches New Era in Global Glacier Diplomacy
Global Leaders Urged to Fund UN Trust for Glacier Preservation
